SCHEMBL7807516

SCHEMBL7807516

O=C1N=CC(C#CC2CC2)(C(F)(F)F)c2cc(Cl)ccc2N1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 9/20 0.58
NR1I2 O75469 1/20 0.57
NR3C1 P04150 1/20 0.57
PGR P06401 1/20 0.57
ADRB1 P08588 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
MAPT P10636 1/20 0.57
CNR1 P21554 1/20 0.57
SLC6A2 P23975 1/20 0.57
HTR2A P28223 1/20 0.57
HTR2C P28335 1/20 0.57
MAPK1 P28482 1/20 0.57
AGTR1 P30556 1/20 0.57
CCKBR P32239 1/20 0.57
PPARG P37231 1/20 0.57
OPRK1 P41145 1/20 0.57
SLC6A3 Q01959 1/20 0.57
PDE4D Q08499 1/20 0.57
PDE3A Q14432 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7807509 1.00 CYP46A1 (0.58) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7811550 1.00 CYP46A1 (0.58) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7906366 0.87 CYP46A1 (0.53) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7814627 0.87 CYP46A1 (0.53) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7904926 0.87 CYP46A1 (0.53) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7903984 0.82 CYP46A1 (0.40) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7802741 0.82 CYP46A1 (0.40) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7897555 0.82 CYP46A1 (0.40) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7811865 0.81 CYP46A1 (0.41) CYP46A1NR1I2NR3C1PGRADRB1
SCHEMBL7808948 0.81 CYP46A1 (0.41) CYP46A1NR1I2NR3C1PGRADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091944-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-04-18 EP claimed
US-6204262-B1 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors DUPONT PHARMACEUTICALS COMPANY 2001-03-20 US claimed
WO-2000000479-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-06 WO claimed
EP-1091944-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-04-18 EP disclosed
US-6204262-B1 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors DUPONT PHARMACEUTICALS COMPANY 2001-03-20 US disclosed
WO-2000000479-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-06 WO disclosed